Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Penicillamine-induced myasthenia |
Causative agent (attribute) |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
3 |
Penicillamine nephropathy |
Causative agent (attribute) |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine adverse reaction |
Causative agent (attribute) |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Allergy to penicillamine (finding) |
Causative agent (attribute) |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
|
Penicillamine [metabolic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
|
Penicillamine [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
|
Penicillamine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
|
Penicillamine 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
|
Penicillamine 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
|
Penicillamine 125 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
|
Product containing precisely penicillamine 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
|
Product containing penicillamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Allergy to penicillamine (finding) |
Causative agent (attribute) |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 125 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 125 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely penicillamine 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely penicillamine 250 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 125 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely penicillamine 250 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Product containing only penicillamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Product containing only penicillamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine therapy |
Direct substance |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Pseudoxanthoma elasticum caused by penicillamine |
Causative agent (attribute) |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |
Penicillamine-induced myasthenia |
Causative agent (attribute) |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
2 |
Penicillamine-induced myasthenia |
Causative agent (attribute) |
True |
Penicillamine (substance) |
Inferred relationship |
Some |
1 |